GR3026467T3 - Imidazole compounds, their preparation and use - Google Patents
Imidazole compounds, their preparation and useInfo
- Publication number
- GR3026467T3 GR3026467T3 GR980400651T GR980400651T GR3026467T3 GR 3026467 T3 GR3026467 T3 GR 3026467T3 GR 980400651 T GR980400651 T GR 980400651T GR 980400651 T GR980400651 T GR 980400651T GR 3026467 T3 GR3026467 T3 GR 3026467T3
- Authority
- GR
- Greece
- Prior art keywords
- preparation
- imidazole compounds
- compounds
- epilepsia
- parkinsonism
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Lubricants (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Eye Examination Apparatus (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72002191A | 1991-06-24 | 1991-06-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3026467T3 true GR3026467T3 (en) | 1998-06-30 |
Family
ID=24892332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR980400651T GR3026467T3 (en) | 1991-06-24 | 1998-03-27 | Imidazole compounds, their preparation and use |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0520200B1 (el) |
JP (1) | JPH05186432A (el) |
AT (1) | ATE163290T1 (el) |
AU (1) | AU653816B2 (el) |
CA (1) | CA2071793A1 (el) |
DE (1) | DE69224448T2 (el) |
DK (1) | DK0520200T3 (el) |
ES (1) | ES2113898T3 (el) |
FI (1) | FI922905A (el) |
GR (1) | GR3026467T3 (el) |
IE (1) | IE921650A1 (el) |
NO (1) | NO302119B1 (el) |
NZ (1) | NZ242951A (el) |
ZA (1) | ZA924117B (el) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK40192D0 (da) * | 1992-03-26 | 1992-03-26 | Neurosearch As | Imidazolforbindelser, deres fremstilling og anvendelse |
DK154092D0 (da) * | 1992-12-23 | 1992-12-23 | Neurosearch As | Imidazolforbindelser, deres fremstilling og anvendelse |
US5554630A (en) * | 1993-03-24 | 1996-09-10 | Neurosearch A/S | Benzimidazole compounds |
AU675484B2 (en) * | 1993-03-24 | 1997-02-06 | Neurosearch A/S | Benzimidazole compounds, their use and preparation |
US5496826A (en) * | 1994-09-02 | 1996-03-05 | Bristol-Myers Squibb Company | Pharmaceutical methods of using heterocyclic derivatives of N-phenylamides |
WO1996033191A1 (en) * | 1995-04-21 | 1996-10-24 | Neurosearch A/S | Benzimidazole compounds and their use as modulators of the gabaa receptor complex |
DE69833858T2 (de) * | 1997-07-08 | 2007-02-22 | Ono Pharmaceutical Co. Ltd. | Aminosäurederivate |
CN1283187A (zh) * | 1997-12-22 | 2001-02-07 | 味之素株式会社 | 新颖二氢吡啶衍生物 |
TWI245035B (en) | 1998-06-26 | 2005-12-11 | Ono Pharmaceutical Co | Amino acid derivatives and a pharmaceutical composition comprising the derivatives |
US6194447B1 (en) | 1998-07-02 | 2001-02-27 | Neurosearch A/S | Bis (benzimidazole) derivatives serving as potassium blocking agents |
WO2000001676A1 (en) * | 1998-07-02 | 2000-01-13 | Neurosearch A/S | Potassium channel blocking agents |
WO2000004005A1 (fr) | 1998-07-14 | 2000-01-27 | Ono Pharmaceutical Co., Ltd. | Derives acides amines et medicaments dont ces derives sont les principes actifs |
AU4329499A (en) | 1998-07-30 | 2000-02-21 | Warner-Lambert Company | Reduced dipeptide analogues as calcium channel antagonists |
EP1191021A4 (en) | 1999-06-23 | 2002-08-07 | Ajinomoto Kk | Dihydropyridine derivative |
US7115645B2 (en) | 2000-01-14 | 2006-10-03 | Schering Aktiengesellschaft | 1,2 diarylbenzimidazoles and their pharmaceutical use |
NZ519326A (en) * | 2000-01-14 | 2005-02-25 | Schering Ag | 1,2-diarylbenzimidazoles for treating diseases that are associated with a microglia activation |
US7329679B2 (en) | 2000-01-27 | 2008-02-12 | Schering Aktiengesellschaft | 1,2 Diarylbenzimidazoles and their pharmaceutical use |
DE10135050A1 (de) * | 2001-07-09 | 2003-02-06 | Schering Ag | 1-Ary1-2-N-, S- oder O-substituierte Benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate |
KR100873400B1 (ko) * | 2002-10-17 | 2008-12-11 | 한국과학기술연구원 | N-타입 칼슘 채널의 활성을 억제함으로써 우울증을감소시키는 방법 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4492708A (en) * | 1982-09-27 | 1985-01-08 | Eli Lilly And Company | Antiviral benzimidazoles |
JPS6474A (en) * | 1987-01-29 | 1989-01-05 | Otsuka Pharmaceut Factory Inc | Benzimidazole derivative |
JPH0772181B2 (ja) * | 1989-06-26 | 1995-08-02 | 株式会社大塚製薬工場 | ベンズイミダゾール誘導体 |
NZ239540A (en) * | 1990-09-24 | 1993-11-25 | Neurosearch As | 1-phenyl benzimidazole derivatives and medicaments |
-
1992
- 1992-05-27 AT AT92108983T patent/ATE163290T1/de active
- 1992-05-27 DE DE69224448T patent/DE69224448T2/de not_active Expired - Lifetime
- 1992-05-27 EP EP92108983A patent/EP0520200B1/en not_active Expired - Lifetime
- 1992-05-27 DK DK92108983T patent/DK0520200T3/da active
- 1992-05-27 ES ES92108983T patent/ES2113898T3/es not_active Expired - Lifetime
- 1992-05-29 NZ NZ242951A patent/NZ242951A/en not_active IP Right Cessation
- 1992-05-29 AU AU17267/92A patent/AU653816B2/en not_active Ceased
- 1992-06-05 ZA ZA924117A patent/ZA924117B/xx unknown
- 1992-06-22 CA CA002071793A patent/CA2071793A1/en not_active Abandoned
- 1992-06-22 FI FI922905A patent/FI922905A/fi unknown
- 1992-06-23 JP JP4165075A patent/JPH05186432A/ja active Pending
- 1992-06-23 NO NO922475A patent/NO302119B1/no not_active IP Right Cessation
- 1992-07-01 IE IE165092A patent/IE921650A1/en unknown
-
1998
- 1998-03-27 GR GR980400651T patent/GR3026467T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0520200T3 (da) | 1998-09-23 |
NZ242951A (en) | 1994-12-22 |
NO922475D0 (no) | 1992-06-23 |
NO302119B1 (no) | 1998-01-26 |
IE921650A1 (en) | 1992-12-30 |
AU1726792A (en) | 1993-01-07 |
ZA924117B (en) | 1993-03-31 |
FI922905A0 (fi) | 1992-06-22 |
NO922475L (no) | 1992-12-28 |
ES2113898T3 (es) | 1998-05-16 |
FI922905A (fi) | 1992-12-25 |
DE69224448T2 (de) | 1998-06-10 |
JPH05186432A (ja) | 1993-07-27 |
EP0520200B1 (en) | 1998-02-18 |
AU653816B2 (en) | 1994-10-13 |
CA2071793A1 (en) | 1992-12-25 |
DE69224448D1 (de) | 1998-03-26 |
EP0520200A2 (en) | 1992-12-30 |
EP0520200A3 (en) | 1993-05-12 |
ATE163290T1 (de) | 1998-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0520200A3 (en) | Imidazole compounds, their preparation and use | |
MY131298A (en) | 5-heteroyl indole derivatives | |
SI0725779T1 (el) | ||
HU9302496D0 (en) | Method for producing anti-viral nucleoside combinations and one for preparing medical preparatives containing said compounds | |
IL104006A (en) | Azaheterocyclylmethyl-chromans their preparation and pharmaceutical compositions containing them | |
AU2626492A (en) | 2- aminomethyl-chromans | |
BG101118A (en) | Therapeutical compounds | |
HK1029916A1 (en) | Use of inosine for the manufacture of a medicamentfor stimulating axonal outgrowth of central nervous system neurons. | |
BR9712259A (pt) | Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo. | |
MX9200361A (es) | Nuevo uso del antagonista de adenosina. | |
ZA947957B (en) | Substituted 1-naphthyl-3-pyrazolecarboxamides which are active in neurotensin their preparation and pharmaceutical compositions containing them | |
MX9403088A (es) | Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso. | |
MY110149A (en) | Compounds for the treatment of neurodegenerative disorders | |
PL310950A1 (en) | Novel imidazole quinoxalinones, method of obtaining them and their application | |
ZA893310B (en) | Novel strobilurine derivatives,their preparation and their use | |
ITRM910085A0 (it) | Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo. | |
IT1274012B (it) | N-acetiltriptamine-2-sostituite, antagoniste ad elevata affinita' del recettore della melatonina | |
ZA932062B (en) | Indole and indazole derivatives, for the treatment and prophylaxis of cerabral disorders, their preparation and their use | |
MX9800697A (es) | Uso de glicosidos de calendula para el tratamiento de psoriasis. |